Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Courting Inspiration: How the Health Humanities Can Pattern the Imagination of Physicians to Resolve Medicine's Epistemic Crisis.

The Journal of medical humanities·2026
Same author

Childhood Trauma in People with Psychosis: Implications for Emotion Awareness and Regulation.

Psychosis·2025
Same author

Health Equity Is No Spectator Sport: The Radical Rooting of a Post-Pandemic Bioethics.

Perspectives in biology and medicine·2022
Same author

The Wayback Machine.

Perspectives in biology and medicine·2022
Same author

The triple helix of clinical, research, and education missions in academic health centers: A qualitative study of diverse stakeholder perspectives.

Learning health systems·2021
Same author

Review of serum prolactin levels as an antipsychotic-response biomarker.

Open access journal of translational medicine & research·2021

Related Experiment Video

Updated: May 21, 2026

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex
04:44

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Published on: February 16, 2024

Paliperidone palmitate for schizophrenia.

Abraham M Nussbaum1, T S Stroup

  • 1Behavioural Health Service, Denver Health, Denver, CO, USA. abraham.nussbaum@dhha.org.

The Cochrane Database of Systematic Reviews
|June 15, 2012
PubMed
Summary
This summary is machine-generated.

Paliperidone palmitate, an antipsychotic, demonstrates greater efficacy than placebo in short-term schizophrenia trials, with comparable tolerability to risperidone long-acting injection. Adverse effects include weight gain and elevated prolactin levels.

More Related Videos

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
08:38

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents

Published on: September 1, 2011

Related Experiment Videos

Last Updated: May 21, 2026

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex
04:44

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Published on: February 16, 2024

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
08:38

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents

Published on: September 1, 2011

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Trials

Background:

  • Paliperidone palmitate is a long-acting injectable antipsychotic for schizophrenia.
  • It is an active metabolite of risperidone, also available orally.

Purpose of the Study:

  • To compare paliperidone palmitate with other treatments for schizophrenia.
  • Evaluate efficacy and adverse effects against placebo and risperidone long-acting injection.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs).
  • Data extracted and analyzed on an intention-to-treat basis.
  • Calculated risk ratios (RR), confidence intervals (CI), and number needed to benefit/harm (NNB/H).

Main Results:

  • Paliperidone palmitate showed improved efficacy over placebo, reducing early study withdrawal, improving global state, and decreasing psychosis recurrence.
  • Associated with fewer reports of agitation/aggression and reduced need for anxiolytic medication.
  • Significant increase in serum prolactin and weight gain observed; no evidence of sexual dysfunction in short-term trials.
  • Compared to risperidone long-acting injection, no significant differences in study withdrawal or psychosis recurrence were found.
  • Fewer participants receiving paliperidone palmitate required anticholinergic medication.

Conclusions:

  • Paliperidone palmitate is more efficacious than placebo in short-term schizophrenia treatment.
  • Adverse effects are similar to related compounds, with increased weight gain and prolactin levels.
  • Efficacy and tolerability appear comparable to risperidone long-acting injection at specified flexible doses.